Literature DB >> 19910736

Reasons for pretreatment attrition and dropout from methylphenidate in adults with attention-deficit/hyperactivity disorder: the role of comorbidities.

Marcelo M Victor, Eugenio H Grevet, Carlos A I Salgado, Katiane L Silva, Nyvia O Sousa, Rafael G Karam, Eduardo S Vitola, Felipe A Picon, Gregory D Zeni, Veronica Contini, Luis A P Rohde, Paulo Belmonte-de-Abreu, Claiton H D Bau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910736     DOI: 10.1097/JCP.0b013e3181c00b1e

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  7 in total

1.  Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD.

Authors:  B S da Silva; R B Cupertino; D L Rovaris; J B Schuch; D B Kappel; D Müller; C E Bandeira; M M Victor; R G Karam; N R Mota; L A Rohde; V Contini; E H Grevet; C H D Bau
Journal:  Mol Psychiatry       Date:  2017-05-02       Impact factor: 15.992

2.  Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD.

Authors:  Verônica Contini; Marcelo M Victor; Caio C S Cerqueira; Evelise R Polina; Eugênio H Grevet; Carlos A I Salgado; Rafael G Karam; Eduardo S Vitola; Paulo Belmonte-de-Abreu; Claiton H D Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-11-20       Impact factor: 5.270

3.  Response to methylphenidate in children and adolescents with ADHD: does comorbid anxiety disorders matters?

Authors:  Sheila P Garcia; Julia Guimarães; Juliana F Zampieri; Ana Luiza Martinez; Guilherme Polanczyk; Luis Augusto Rohde
Journal:  J Neural Transm (Vienna)       Date:  2009-04-16       Impact factor: 3.575

4.  ADHD and Anxiety: Clinical Significance and Treatment Implications.

Authors:  Frederick W Reimherr; Barrie K Marchant; Thomas E Gift; Tammy A Steans
Journal:  Curr Psychiatry Rep       Date:  2017-11-20       Impact factor: 5.285

5.  Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.

Authors:  Verônica Contini; Marcelo M Victor; Francine Z C Marques; Guilherme P Bertuzzi; Carlos A I Salgado; Katiane L Silva; Nyvia O Sousa; Eugenio H Grevet; Paulo Belmonte-de-Abreu; Claiton H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2010-01-05       Impact factor: 3.575

6.  Insights from pre-treatment attrition & dropouts in an effectiveness trial of methylphenidate in children.

Authors:  Ruchita Shah; Susanta Padhy; Adarsh Kohli; Samita Sharma
Journal:  Indian J Med Res       Date:  2020-09       Impact factor: 2.375

7.  Integrative proteomics and pharmacogenomics analysis of methylphenidate treatment response.

Authors:  Bruna S da Silva; Douglas T Leffa; Walter O Beys-da-Silva; Iraci L S Torres; Diego L Rovaris; Marcelo M Victor; Luis A Rohde; Nina R Mota; Carla de Oliveira; Markus Berger; John R Yates; Renuka Sabnis; Ramón Díaz Peña; Alexandre Rosa Campos; Eugenio H Grevet; Lucelia Santi; Claiton H D Bau; Verônica Contini
Journal:  Transl Psychiatry       Date:  2019-11-18       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.